GlycoNex Incorporation (TPEX:4168)
23.80
-0.30 (-1.24%)
Apr 17, 2026, 1:30 PM CST
GlycoNex Incorporation Market Cap
GlycoNex Incorporation has a market cap or net worth of 2.58 billion as of April 17, 2026. Its market cap has decreased by -0.83% in one year.
Market Cap
2.58B
Enterprise Value
2.36B
Revenue
37.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.80
Market Cap Chart
Since December 16, 2011, GlycoNex Incorporation's market cap has increased from 1.51B to 2.58B, an increase of 70.84%. That is a compound annual growth rate of 3.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.58B | -7.57% |
| Dec 31, 2025 | 2.79B | 2.79% |
| Dec 31, 2024 | 2.71B | -16.13% |
| Dec 29, 2023 | 3.23B | -0.89% |
| Dec 30, 2022 | 3.26B | 13.02% |
| Dec 30, 2021 | 2.89B | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apex Biotechnology | 2.96B |
| Intech Biopharm | 2.93B |
| Syngen Biotech | 2.89B |
| HeXun Biosciences | 2.80B |
| Sunhawk Vision Biotech | 2.73B |
| TWi Biotechnology | 2.70B |
| Sinew Pharma | 2.67B |
| Genomics BioSci & Tech. | 2.53B |